🎯Moderna’s success was built on regulatory shortcuts Moderna is scaling back vaccine investment as regulators raise the evidentiary bar, exposing how regulatory shortcuts underpinned approval of its Covid vaccine. STORY LINK 👇👇 @jeffreytucker @newstart_2024